Amgen Inc.
Explore Amgen Inc.
Core profile pages, annual revenue records, and related research hubs for this company.
CorpDigest
Amgen Inc.
Explore Amgen Inc.
Core profile pages, annual revenue records, and related research hubs for this company.
Annual Revenue
FY2024 Revenue
$33.4B
▲ 18.6% vs FY2023 ($28.2B)
Net Income: $3.8B
Source: Annual report / company filing
Amgen Inc. reported $33.4B in revenue for fiscal year 2024. This represents a growth of 18.6% compared to the 2023 figure of $28.2B. In 2025, revenue increased to $36.8B.
A 19% jump, largely from the $27.8B Horizon Therapeutics acquisition closing.
| Year | Revenue | Net Income | YoY Change |
|---|---|---|---|
| FY2025 | $36.8B | — | +10.0% |
| FY2024 | $33.4B | $3.8B | +18.6% |
| FY2023 | $28.2B | — | +7.1% |
| FY2022 | $26.3B | — | +1.3% |
| FY2021 | $26.0B | — | +2.2% |
| FY2020 | $25.4B | — | — |
Source: SEC EDGAR filings, annual earnings releases, and verified financial disclosures.